Very small embryonic-like stem cell therapy (Fuda Cancer Hospital)

极小胚胎样干细胞（复大肿瘤医院）

Report date: 2022/07/19 20:00:45

Base Information

Drug NameVery small embryonic-like stem cell therapy (Fuda Cancer Hospital)

Drug Alias NameVSEL

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Stem cell therapy > Very small embryonic-like stem cell therapyCell and gene therapy > Cell therapy > Source of cells > Peripheral blood-derived

Mechanisms of ActionCell replacements

TargetsNot applicable

Therapy Area/IndicationsDermatitisPrimary Ovarian InsufficiencyOsteoarthritis, Knee +[4]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaDiscontinued

Originator CompaniesFuda Cancer Hospital

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesFuda Cancer Hospital

Active IndicationsN/A

Inactive IndicationsDermatitisPrimary Ovarian InsufficiencyOsteoarthritis, Knee +[4]

Other Information

ATC CodeN/A